Market Overview The Histone Deacetylase HDAC Inhibitors Market is expanding as epigenetic-targeted cancer therapies gain broader clinical adoption, particularly in hematologic malignancies. Growth through 2030 will be driven by expanding indications, combination therapy research, and rising global cancer incidence. Current Market Landscape HDAC inhibitors approved for certain lymphomas and...